Columbia Asset Management purchased a new stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) in the second quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 11,476 shares of the pharmacy operator’s stock, valued at approximately $898,000.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Hudock Capital Group LLC raised its holdings in Walgreens Boots Alliance by 0.5% in the second quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock worth $102,000 after buying an additional 6 shares during the last quarter. Reilly Financial Advisors LLC raised its holdings in Walgreens Boots Alliance by 7.9% in the second quarter. Reilly Financial Advisors LLC now owns 1,367 shares of the pharmacy operator’s stock worth $107,000 after buying an additional 100 shares during the last quarter. Orrstown Financial Services Inc. raised its holdings in Walgreens Boots Alliance by 14.1% in the second quarter. Orrstown Financial Services Inc. now owns 1,728 shares of the pharmacy operator’s stock worth $135,000 after buying an additional 213 shares during the last quarter. Founders Capital Management purchased a new position in Walgreens Boots Alliance in the first quarter worth about $161,000. Finally, Hanson McClain Inc. raised its holdings in Walgreens Boots Alliance by 4.6% in the second quarter. Hanson McClain Inc. now owns 1,987 shares of the pharmacy operator’s stock worth $156,000 after buying an additional 87 shares during the last quarter. 63.79% of the stock is owned by institutional investors.

A number of analysts have recently commented on WBA shares. Royal Bank Of Canada started coverage on shares of Walgreens Boots Alliance in a research note on Tuesday, September 19th. They issued an “outperform” rating and a $96.00 price target for the company. Needham & Company LLC reiterated a “buy” rating and issued a $94.00 price target on shares of Walgreens Boots Alliance in a research note on Saturday, September 16th. BidaskClub lowered shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Tuesday, September 12th. Jefferies Group LLC reiterated a “buy” rating and issued a $95.00 price target on shares of Walgreens Boots Alliance in a research note on Thursday, September 7th. Finally, UBS AG reiterated a “buy” rating and issued a $96.00 price target (down from $97.00) on shares of Walgreens Boots Alliance in a research note on Wednesday, August 23rd. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and fourteen have given a buy rating to the stock. The stock has an average rating of “Buy” and a consensus target price of $87.63.

TRADEMARK VIOLATION WARNING: “Columbia Asset Management Invests $898,000 in Walgreens Boots Alliance, Inc. (WBA) Stock” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this story on another publication, it was stolen and republished in violation of U.S. & international trademark and copyright law. The correct version of this story can be viewed at https://www.thecerbatgem.com/2017/11/08/columbia-asset-management-invests-898000-in-walgreens-boots-alliance-inc-wba-stock.html.

In related news, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction on Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total transaction of $184,324.32. Following the sale, the director now owns 16,415 shares of the company’s stock, valued at $1,105,878.55. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director John Anthony Lederer purchased 20,000 shares of the firm’s stock in a transaction that occurred on Thursday, October 26th. The shares were acquired at an average cost of $67.00 per share, for a total transaction of $1,340,000.00. Following the purchase, the director now owns 50,000 shares of the company’s stock, valued at $3,350,000. The disclosure for this purchase can be found here. 13.50% of the stock is owned by corporate insiders.

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) opened at $67.92 on Wednesday. Walgreens Boots Alliance, Inc. has a 1-year low of $63.82 and a 1-year high of $88.00. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.07 and a quick ratio of 0.59. The company has a market cap of $68,450.00, a price-to-earnings ratio of 13.11, a PEG ratio of 1.19 and a beta of 1.20.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.21 by $0.10. The company had revenue of $30.15 billion for the quarter, compared to the consensus estimate of $29.93 billion. Walgreens Boots Alliance had a net margin of 3.45% and a return on equity of 18.36%. Walgreens Boots Alliance’s revenue was up 5.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.07 earnings per share. research analysts expect that Walgreens Boots Alliance, Inc. will post 5.55 EPS for the current fiscal year.

Walgreens Boots Alliance announced that its Board of Directors has authorized a stock buyback plan on Wednesday, October 25th that permits the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization permits the pharmacy operator to buy shares of its stock through open market purchases. Shares repurchase plans are typically an indication that the company’s management believes its stock is undervalued.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Monday, November 13th will be paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 2.36%. The ex-dividend date is Friday, November 10th. Walgreens Boots Alliance’s payout ratio is 42.33%.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Stock Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related stocks with our FREE daily email newsletter.